# CETIRIZINE HYDROCHLORIDE ALLERGY
> **ANDA213105** · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT · Approved 2020-09-21
## Drug
- **FDA Application Number:** ANDA213105
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CETIRIZINE HYDROCHLORIDE ALLERGY
- **Generic name:** CETIRIZINE HCL
- **Active ingredients:** CETIRIZINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** CATALENT
- **Manufacturer:** WALMART INC. (see also Equate)
- **First approval:** 2020-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213105)
---
*AI Analytics · CC0 1.0*